Insider Transactions in Q1 2024 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2024
|
Justin J. Mc Anear |
BUY
Grant, award, or other acquisition
|
Direct |
53,312
+26.41%
|
-
|
|
Mar 21
2024
|
Benjamin J. Hindson |
BUY
Grant, award, or other acquisition
|
Direct |
71,083
+16.72%
|
-
|
|
Mar 21
2024
|
Serge Saxonov Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,854
+9.04%
|
-
|
|
Mar 14
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,086
-0.13%
|
-
|
|
Mar 04
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,660
-0.55%
|
$205,040
$44.0 P/Share
|
|
Feb 22
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,821
-0.33%
|
$129,766
$46.34 P/Share
|
|
Feb 22
2024
|
Justin J. Mc Anear |
SELL
Open market or private sale
|
Direct |
1,865
-1.92%
|
$85,790
$46.34 P/Share
|
|
Feb 22
2024
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
2,613
-0.91%
|
$120,198
$46.34 P/Share
|
|
Feb 15
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.29%
|
$245,000
$49.01 P/Share
|
|
Feb 09
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.12%
|
$49,000
$49.53 P/Share
|
|
Jan 16
2024
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-0.23%
|
$180,000
$45.38 P/Share
|